H 4532

  • Massachusetts House Bill
  • 191st Legislature (2019-2020)
  • Introduced in House
  • House
  • Senate
  • Governor

An Act relative to opioid drug manufacturer assessments

Votes


No votes to display

Actions


Jun 22, 2020

House

Reporting date extended to Thursday December 31, 2020, pending concurrence

Apr 30, 2020

Senate

Senate concurred

Apr 29, 2020

House

Reporting date extended to Friday June 19, 2020, pending concurrence

Mar 26, 2020

Senate

Senate concurred

Mar 23, 2020

House

Reporting date extended to Friday May 1, 2020, pending concurrence

Mar 09, 2020

House

Reported from the committee on Mental Health, Substance Use and Recovery

House

Reported favorably by committee and referred to the committee on Health Care Financing

  • Referral-Committee
committee on Health Care Financing the committee on Health Care Financing

House

New draft of H1703

Bill Text

Bill Text Versions Format
Bill Text PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Massachusetts General Court.

If you notice any inconsistencies with these official sources, feel free to file an issue.